Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas

(2016) Semra Paydas et al.   MEDICAL ONCOLOGY

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma

(2016) Asma Beldi-Ferchiou et al.   Oncotarget

Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy

(2016) David J. Pinato et al.   OncoImmunology

Facing up to the ongoing challenge of Kaposiʼs sarcoma

(2015) Rebecca C. Robey et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Malignancies in HIV/AIDS

(2014) Paul G. Rubinstein et al.   AIDS

Immunosenescence is associated with presence of Kaposiʼs sarcoma in antiretroviral treated HIV infection

(2013) Patrick Unemori et al.   AIDS

Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm3at presentation

(2013) M.-L. Daly et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

(2013) B. J. Chen et al.   CLINICAL CANCER RESEARCH

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era

(2013) A. Mocroft et al.   CLINICAL INFECTIOUS DISEASES

Nivolumab plus Ipilimumab in Advanced Melanoma

(2013) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Immunotherapy

(2013) J. Couzin-Frankel   SCIENCE

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

(2012) Suzanne L Topalian et al.   CURRENT OPINION IN IMMUNOLOGY

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual biological effects of the cytokines interleukin-10 and interferon-γ

(2011) Cailin Moira Wilke et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The effect of HAART in 254 consecutive patients with AIDS-related Kaposiʼs sarcoma

(2009) Mark Bower et al.   AIDS

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

(2009) M. Ahmadzadeh et al.   BLOOD